Literature DB >> 2391112

Sexually transmitted diseases amongst pregnant Vietnamese refugees in Hong Kong.

P A King1, S J Duthie, H K Ma.   

Abstract

In a prospective study the prevalence of syphilis amongst a group of pregnant Vietnamese refugees in Hong Kong was found to be 3.4%. No cases of gonorrhoea, genital warts or genital ulcers were found in the same group of patients. The implications of these results are discussed and the importance of adequate screening, treatment, contact tracing and health education amongst this group are emphasised.

Entities:  

Keywords:  Asia; Demographic Factors; Developing Countries; Diseases; Eastern Asia; Examinations And Diagnoses; Gonorrhea; Hong Kong; Infections; Measurement; Migrants; Migration; Obstacles; Organization And Administration; Population; Population Dynamics; Pregnancy; Prevalence; Refugees; Reproduction; Reproductive Tract Infections; Research Methodology; Screening; Sexually Transmitted Diseases; Southeastern Asia; Syphilis; Viet Nam

Mesh:

Year:  1990        PMID: 2391112      PMCID: PMC1194525          DOI: 10.1136/sti.66.4.257

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  3 in total

1.  Routine serological screening for syphilis during pregnancy--disposable anachronism or fundamental necessity?

Authors:  S J Duthie; P A King; G L Yung; H K Ma
Journal:  Aust N Z J Obstet Gynaecol       Date:  1990-02       Impact factor: 2.100

2.  Pattern of sexually transmitted disease in Madurai, India.

Authors:  P Jeyasingh; T B Ramanaiah; S D Fernandes
Journal:  Genitourin Med       Date:  1985-12

3.  Congenital syphilis. Why is it still occurring?

Authors:  L Mascola; R Pelosi; J H Blount; N J Binkin; C E Alexander; W Cates
Journal:  JAMA       Date:  1984-10-05       Impact factor: 56.272

  3 in total
  1 in total

1.  Safety of benzathine penicillin for preventing congenital syphilis: a systematic review.

Authors:  Tais F Galvao; Marcus T Silva; Suzanne J Serruya; Lori M Newman; Jeffrey D Klausner; Mauricio G Pereira; Ricardo Fescina
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.